Log in to save to my catalogue

Immunophenotypes associated with bipolar disorder and lithium treatment

Immunophenotypes associated with bipolar disorder and lithium treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6877517

Immunophenotypes associated with bipolar disorder and lithium treatment

About this item

Full title

Immunophenotypes associated with bipolar disorder and lithium treatment

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2019-11, Vol.9 (1), p.17453-10, Article 17453

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immune dysfunction is implicated in the etiology of bipolar disorder. The single-nucleotide polymorphism rs17026688 in the gene encoding glutamate decarboxylase–like protein 1 (
GADL1
) has been found to be associated with lithium response in Han Chinese patients with bipolar I disorder (BDI). However, whether patients with
GADL1
polymo...

Alternative Titles

Full title

Immunophenotypes associated with bipolar disorder and lithium treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6877517

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6877517

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-019-53745-7

How to access this item